DevPro Biopharma
Pramila Monte, BSN, MBA, currently serves as the VP, Head of Clinical Safety Management and Portfolio Manager at DevPro Biopharma since July 2020, overseeing the development and delivery of pharmaceutical candidates. Prior experience includes a role as Director of Clinical Trial Safety Management at AstraZeneca, where Pramila led the establishment of the CTSM department, successfully managed safety for numerous studies and facilitated major Health Authority inspections. Additionally, as Associate Director of Pharmacovigilance at Pearl Therapeutics Inc., strategic initiatives in safety management were implemented. Pramila's earlier experience includes managerial roles at Pearl Therapeutics and Ferring Pharmaceuticals, where significant contributions were made in safety reporting and system development. Pramila earned a nursing degree from the University of Medicine and Dentistry of New Jersey.
This person is not in any teams
This person is not in any offices
DevPro Biopharma
DevPro Biopharma is a Clinical Research and Development Accelerator with the mission to design, develop, and deliver molecules into medicines. Our corporate vision is to be a force for continual change in clinical development, focused on bringing medicines to people faster and more efficiently. DevPro Biopharma’s unique capabilities allow the team to span full development programs, with focus on the complete development cycle through global regulatory approvals.